Shares of Sanofi (SNY) have been strong performers lately, with the stock up 9.1% over the past month. The stock hit a new 52-week high of $46.6 in the previous session. Sanofi has gained 7% since the start of the year compared to the 4% move for the Zacks Medical sector and the 4.5% return for the Zacks Large Cap Pharmaceuticals industry.
What's Driving the Outperformance?
The stock has a great record of positive earnings surprises, as it hasn't missed our earnings consensus estimate in any of the last four quarters.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,